Introduction: Primary cancers of the uterine tube are among the rare tumors of the female genital tract, representing less than 2% of gynecologic malignancies. Cases presentation: We report a case of tubal adenocarcinoma diagnosed incidentally on a hysterectomy specimen in a patient followed at the gynecology department. The patient underwent primary reduction surgery followed by six courses of adjuvant chemotherapy with carboplatin and paclitaxel combined with 23 sessions of radiotherapy and two courses of brachytherapy. The patient is in complete remission with a follow-up of 14 months. Clinical discussion: These cancers of unknown etiology are dominated by adenocarcinoma, the clinical signs are often dissociated, and the preoperative diagnosis is difficult. The diagnosis should be made in the presence of any metrorrhagia associated with leucorrhoea in postmenopausal women. The treatment is similar to that of malignant epithelial tumors of the ovary with a prognosis that depends on the stage of the disease. Conclusion: The diagnosis of cancers of the uterine tube is very difficult to confirm because of the proximity of the uterus and the ovary and to evoke in front of any cellular atypia of the cervico-uterine smear associated with adnexal anomalies. Highlights
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.